Science
The race to make COVID antibody therapies cheaper and more potent – Nature.com
Injections of antibodies might prevent mild COVID-19 from becoming severe, but the treatments are expensive and difficult to make.
Human antibodies attacking the coronavirus (artist’s impression).Credit: Science Lab/Alamy
When US President Donald Trump was ill with COVID-19, his physicians administered a bevy of medications some proven, others experimental. But there is one that the president has hailed as a cure: a cocktail of coronavirus antibodies produced by Regeneron Pharmaceuticals in Tarrytown, New York.
The ‘curative’ power of this antibody treatment has yet to be proven. Although it has shown promise in small, early…
Continue Reading
